The reality of drug pricing
By Andrew Willis | 01/03/19
High drug prices have been making headlines recently, with a recent U.S. Senate hearing into the matter earlier this week.
Should investors inject their portfolios with some pharma exposure to get behind this trend? Or are there dangerous side-effects to watch out for when getting behind companies selling thousand-dollar doses?
The world’s two largest economies are outdoing each other to make business easier for clean…
Harvest Portfolios Group…
Harvest Portfolios Group Inc. (“Harvest”) declares…
Harvest Portfolios Group Inc. (“Harvest”) announces the following distributions for Harvest ETFs…
Currency hedging can impact an ETF’s price and overall performance; learn about hedged and unhedged ETFs in Canada here.
Covered calls can deliver consistent monthly income.